Advik Laboratories Ltd — Board Meeting, 28-05-2026: Board Meeting
28-05-2026 | 02:02 pm
28-05-2026 | 02:02 pm
MPS Pharmaa's board has approved its Q4 and full-year audited financial results for FY26. Key takeaways include an audit qualification impact noted and the re-appointment of internal auditors for FY27. Related party transactions were also disclosed.
No comments yet. Be the first to comment!
